文献速递肿瘤 PET/CT甲状腺核医学

68Ga-Trivehexin PET/CT检测复发性甲状旁腺癌

Detection of Recurrent Parathyroid Cancer Using 68 Ga-Trivehexin PET/CT.
PubMed 文献 · Clin Nucl Med · 2025-05-15

一例53岁女性复发性甲状旁腺癌患者,血清甲状旁腺激素和离子钙升高,18F-FDG PET/CT未见病理性摄取,99mTc-MIBI SPECT/CT见可疑摄取,68Ga-Trivehexin PET/CT显示复发灶强烈活性及双肺新发广泛病灶中一处轻度活性(评估为转移)。这是首例报道68Ga-Trivehexin PET/CT检测复发性甲状旁腺癌的病例,提示18F-FDG PET/CT和99mTc-MIBI闪烁显像可能出现假阴性。

要点

  • 68Ga-Trivehexin PET/CT在复发性甲状旁腺癌中显示复发灶强烈活性。
  • 18F-FDG PET/CT未见病理性摄取,99mTc-MIBI SPECT/CT见可疑摄取。
  • 双肺新发广泛病灶中一处见轻度活性,评估为转移。

核心结论

  • 68Ga-Trivehexin PET/CT在检测复发性甲状旁腺癌中具有潜在作用,为首次病例报道。
  • 18F-FDG PET/CT和99mTc-MIBI闪烁显像可能出现假阴性结果。

研究设计与样本

  • 病例报告:一例53岁女性复发性甲状旁腺癌患者。

主要发现

  • 68Ga-Trivehexin PET/CT显示复发灶强烈活性,双肺新发广泛病灶中一处见轻度活性并评估为转移。
  • 18F-FDG PET/CT未见病理性摄取。
  • 99mTc-MIBI SPECT/CT显示可疑摄取。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 53-year-old woman with a history of multiple surgeries due to recurrent parathyroid carcinoma (rPTC) presented with elevated serum parathyroid hormone (PTH) and ionized calcium (Ca) levels. While 18 F-FDG PET/CT showed no pathologic uptake and 99m Tc-MIBI SPECT/CT showed a suspicious uptake, 68 Ga-Trivehexin PET/CT revealed intense activity in the recurrent lesion, as well as mild activity in one of the newly detected, widespread lesions in both lungs, which was assessed as metastatic. This is the first case report demonstrating the potential role of 68 Ga-Trivehexin PET/CT in detecting recurrent PTC, highlighting the possibility of false-negative results with 18 F-FDG PET/CT and 99m Tc-MIBI scintigraphy.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Denizmen Zorba D, Kuyumcu S, Kubat Uzum A, et al. Detection of Recurrent Parathyroid Cancer Using 68 Ga-Trivehexin PET/CT. Clin Nucl Med. 2025. PMID: 40369809. doi:10.1097/RLU.0000000000005735

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。